The Lupus Research Institute is pleased to alert people with lupus of a new Phase III trial testing the efficacy, safety and tolerability of the recently approved Benlysta(r) as a once-a-week injectable rather than the existing intravenous formulation. For more information, visit clinicaltrials.gov and search for trial NCT01484496.